Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Leukemia|January 16, 2024
Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia nicheDing-Wen Chen, Jian-Meng Fan, Julie M Schrey, et al.
Blood|June 12, 2008
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemiaDavid T Teachey, Cecilia Sheen, Junior Hall, et al.
Leukemia & Lymphoma|February 21, 2022
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamideCraig W Freyer, Alison Carulli, Shannon Gier, et al.
Blood Advances|August 21, 2024
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemiaBetty K Hamilton, Bhavik J Pandya, Cristina Ivanescu, et al.
Transplantation and Cellular Therapy|May 9, 2021
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of StayCraig W Freyer, Shannon Gier, Mary E Moyer, et al.
Transplantation and Cellular Therapy|December 16, 2022
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage ChemotherapyAlexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.
Blood Advances|October 6, 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trialMark J Levis, Harry P Erba, Pau Montesinos, et al.
The Lancet. Oncology|June 9, 2019
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trialJorge E Cortes, Samer Khaled, Giovanni Martinelli, et al.
Blood|March 2, 2017
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemiaSarah K Tasian, Saad S Kenderian, Feng Shen, et al.
Cancer Cell|November 14, 2006
Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemiaKaren Keeshan, Yiping He, Bas J Wouters, et al.
Pageof 19